(6aR,9R,10aR)-7-allyl-N9-(3-(dimethylamino)propyl)-N4-ethyl-6a,7,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-4,9(6H)-dicarboxamide; N8-Desethylcarbamoyl-N1-ethylcarbamoyl Cabergoline; (8?)-N8-[3-(Dimethylamino)propyl]-N1-ethyl-6-(2-propen-1-yl)-ergoline-1,8-dicarboxamide; (8?)-N8-[3-(Dimethylamino)propyl]-N1-ethyl-6-(2-propenyl)-ergoline-1,8-dicarboxamide; Cabergoline EP Impurity B; Cabergoline USP Related Compound B ; N8-Desethylcarbamoyl-N1-ethylcarbamoyl Cabergoline
Cabergoline EP Impurity B is a fully characterized chemical compound used as a reference standard of API Cabergoline. The standard offered is compliant with regulatory guidelines. Cabergoline EP Impurity B is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 166533-36-4
